"The U.S. Food and Drug Administration today approved Hysingla ER (hydrocodone bitartrate), an extended-release (ER) opioid analgesic to treat pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternat"...
Lortab 7.5/500 tablets (Hydrocodone Bitartrate and Acetaminophen Tablets, USP, 7.5 mg/500 mg) are indicated for the relief of moderate to moderately severe pain.
DOSAGE AND ADMINISTRATION
Dosage should be adjusted according to severity of pain and response of the patient. However, it should be kept in mind that tolerance to hydrocodone can develop with continued use and that the incidence of untoward effects is dose related.
The usual adult dosage is one tablet every four to six hours as needed for pain. The total daily dosage should not exceed 6 tablets.
Lortab ® 7.5/500 tablets (Hydrocodone Bitartrate and Acetaminophen Tablets, USP, 7.5 mg/500 mg) contain hydrocodone bitartrate 7.5 mg and acetaminophen 500 mg. They are supplied as white with green specks, capsule-shaped, bisected tablets, debossed "ucb" on one side and "903" on the other side, in containers of 100 tablets NDC 50474-907-01, and 500 tablets NDC 50474-907-50.
STORAGE: Store at 20 to 25°C (68 to 77°F). [see USP Controlled Room Temperature]
Dispense in a tight, light-resistant container with a child-resistant closure.
A Schedule CIII Narcotic
Manufactured for: UCB Pharma, Inc. Smyrna, GA 30080. Manufactured by: Mikart, Inc. Atlanta, GA 30318. Rev. 03/2004. FDA rev date: 8/3/2000
Last reviewed on RxList: 1/30/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Lortab 7.5 Information
Report Problems to the Food and Drug Administration
Chronic Pain/Back Pain
Find tips and advances in treatment.